Equity-crowdfunding issuers and the rounds they've run.
Software & AI
Biotech
A preclinical-stage biotechnology company developing BT-1501, an oral investigational therapy designed for APC-mutant colorectal cancer — a mutation commonly found in ~80% of CRC patients. Backed by $17 million in non-dilutive funding from the Cancer Prevention & Research Institute of Texas (CPRIT) and support/investment from the American Cancer Society, Barricade is preparing for first-in-human studies.
Software & AI
Intelligent Voice Commerce
New York, NY
Food & Beverage
Transportation
Own your time
Biotech
Neurotez Inc. is developing a drug to treat Leptin deficiency in Alzheimer’s patients.
Software & AI
Your data. Your decisions
Energy & Cleantech
Aims to eliminate PFAS and other high health risk chemicals from water worldwide
Alcohol
Software & AI
Transforming communications at the Speed of Light
Media & Entertainment
Food & Beverage · Packaged Drink
Non-alcoholic beer for all walks of life
Retail & Consumer · Product
A new paragon in coffee
Media & Entertainment
Veteran PC & mobile developer and publisher creating two next-gen action RPG games
Travel & Hospitality
Alcohol
Media & Entertainment
Murray, UT
Software & AI
Complimentary appetizers whenever you dine out
Food & Beverage
Fintech
Instant transactions using highly accurate voice identification & verification
Healthcare
Innovator of the First 100% Cosmos Natural Sunscreens & Application Technology
Van Nuys, CA
